T1	Participants 51 78	endobronchial tumor lesions
T2	Participants 152 182	endoscopically visible lesions
T3	Participants 653 704	296 patients with visible endoluminal tumor lesions
T4	Participants 1761 1789	endobronchial tumor lesions.
